Advertisement

Science News

Most People Who Need Hepatitis C Treatment Aren’t Getting It

illustration liver

Resmetirom Improves NASH and Liver Fibrosis in Phase III Trial

Blogs: The Community Speaks

HCV Virus

Most People Who Need Hepatitis C Treatment Aren’t Getting It

illustration liver

Resmetirom Improves NASH and Liver Fibrosis in Phase III Trial

Blogs: The Community Speaks

HCV Testing at Safe Injection Site Improves Treatment Uptake

Hepatitis C prevalence was higher among people with unstable housing and those who injected drugs every day.

Fatty Liver Disease Linked to Cardiovascular Risk in People with HIV

NAFLD is associated with risk factors such as obesity and inflammatory biomarkers and with events including heart attacks and strokes.

Black and Latino People Are Less Likely to Receive Liver Transplants

In 2018, Black and Latino patients with advanced cirrhosis had a higher risk of mortality compared with white people.

People on Medicaid Are Missing Out on Hepatitis C Treatment

Only 20% of people covered by Medicaid received treatment within six months of their HCV diagnosis.

Vosevi Is Effective for Retreatment of Hepatitis C

Adding ribavirin led to more side effects but did not improve the likelihood of a cure.

One Third of People With Hepatitis C Are Unaware of Their Status

Older people, men and people living in poverty and lacking private insurance were more likely to have active HCV infection.

MUST read

Celebrities With Hepatitis

10 Tips to Protect Your Liver

Hep Stories: Get inspired

liver, liver cancer

The Causes of Liver Cancer Are Changing

angry yellow liver illustration

What’s in the Pipeline for NAFLD and NASH Treatment?

11 Signs of Liver Disease

Only 1 in 5 U.S. Adults With Opioid Use Disorder Received Medications to Treat it in 2021

NIH and CDC study finds telehealth associated with increased likelihood of receiving evidence-based standard of care.

Striving for a Healthier Future: Combating HIV and Hepatitis C Coinfection

The CDC estimates that 21% of people living with HIV also have hepatitis C virus.

New Viral Hepatitis Surveillance Report Shows Rise in Hepatitis C

Hepatitis A and B declined in 2021, but new hepatitis C cases have doubled since 2014.

Latinos See Overall Decline in Cancer Deaths

However, liver cancer mortality has risen for both Latino men and women.

People With Hepatitis C Still Have Higher Mortality After Being Cured

Drug-related mortality, including overdose, was the leading cause of death.

Hot topics

Hepatitis C: The Basics

Hepatitis B: The Basics

Hepatitis A: The Basics

NASH: The Basics

COVID-19 Vaccination and Boosting During Pregnancy Benefits Pregnant People and Newborns

Antibodies crossed the placenta, likely conferring some protection for newborns immediately after birth.

Is Fatty Liver Disease a Risk Factor for Cardiovascular Disease?

For people with NAFLD or NASH, treating metabolic problems may offer benefits beyond liver disease.

People With NASH Fare Worse Than Those With Diabetes

Advanced fatty liver disease led to a greater need for medical care and more difficulty with daily activities.

NASH Is Major Cause of Liver Cancer Among Transplant Candidates

In 2022, fatty liver disease accounted for nearly a quarter of all liver cancer cases on the transplant waiting list.

NIH Launches Long COVID Clinical Trials Through RECOVER Initiative

The first studies, launched on July 31, will focus on viral persistence and cognitive dysfunction.

Advertisement

Newsfeed

Features

Hot topics

Forums: Support and discussion

Blogs: The community speaks

Hep Stories: Get inspired

Magazine: Search the archives

#Coffee

A smiling Caucasian couple

#BabyBoomers